Get started
Author

Elisa Schiavoni

Observed names: E Schiavoni, E. Schiavoni, E., Schiavoni, Elisa SCHIAVONI, Schiavoni Elisa, Schiavoni, Elisa
ORCID: 0000-0001-5223-9345
Observed ORCID: 0000-0001-5223-9345
OpenAlex ID: A5082507030
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders
2017 · Loris Riccardo Lopetuso, Valentina Petito, et al. · Digestive Diseases · 168
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center
2019 · Marco Pizzoferrato, Roberto de Sire, et al. · Nutrients · 73
PDF
Impact of COVID‐19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high‐volume Italian inflammatory bowel disease centre
2020 · Franco Scaldaferri, Daniela Pugliese, et al. · United European Gastroenterology Journal · 45
PDF
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
2022 · Laurent Peyrin-Biroulet, Jean-François Rahier, et al. · Clinical Gastroenterology and Hepatology · 41
PDF
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis
2016 · F. Scaldaferri, S. Pecere, et al. · Transplantation Proceedings · 32
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study
2022 · Antonio Tursi, Giammarco Mocci, et al. · Inflammatory Bowel Diseases · 31
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center
2023 · Franco Scaldaferri, Antonio Maria D’Onofrio, et al. · Inflammatory Bowel Diseases · 28
Clinical research coordinators: Key components of an efficient clinical trial unit
2023 · Vincenzina Mora, Stefania Colantuono, et al. · Contemporary Clinical Trials Communications · 23
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients
2024 · Daniele Napolitano, Carlo Romano Settanni, et al. · Indian Journal of Gastroenterology · 19
Nursing‐sensitive outcomes in adult inflammatory bowel disease: A systematic review
2021 · Rocco Spagnuolo, Alessandro Corea, et al. · Journal of Advanced Nursing · 19
Nurse Practitioners in Inflammatory Bowel Disease: The Emerging Role of the IBD Care Manager
2022 · Daniele Napolitano, Elisa Schiavoni, et al. · Journal of Gastrointestinal and Liver Diseases · 18
Effect of a Multistrain Probiotic on Leaky Gut in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study
2022 · Samira Ait Abdellah, Caroline Gal, et al. · Digestive Diseases · 16
PDF
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy
2022 · Antonio Tursi, Giammarco Mocci, et al. · Journal of Gastrointestinal and Liver Diseases · 15
PDF
The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study
2022 · Aurelien Amiot, Jean-Francois Rahier, et al. · Journal of Crohn s and Colitis · 15
PDF
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study
2023 · Antonio Tursi, Giammarco Mocci, et al. · Expert Opinion on Pharmacotherapy · 13
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study
2023 · Giammarco Mocci, Antonio Tursi, et al. · Expert Opinion on Biological Therapy · 13
Tu1363 An Open-Label, Pilot Study to Assess Feasibility and Safety of Fecal Microbiota Transplantation in Patients With Mild-Moderate Ulcerative Colitis: Preliminary Results
2015 · Franco Scaldaferri, Silvia Pecere, et al. · Gastroenterology · 11
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission
2023 · Laura Parisio, Carlo Romano Settanni, et al. · Journal of Gastrointestinal and Liver Diseases · 10
PDF
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study
2022 · Alfredo Papa, Franco Scaldaferri, et al. · Biomedicines · 9
PDF
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre.
2020 · Daniele Napolitano, Piergiorgio Martella, et al. · PubMed · 9
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
2023 · Loris Riccardo Lopetuso, Lucrezia Laterza, et al. · Microorganisms · 8
PDF
The Dedicated Inflammatory Bowel Disease Nurse, If You Know Them, You Love Them: Survey of the Italian IBD Patients’ Association
2025 · Daniele Napolitano, Franco Scaldaferri, et al. · Crohn s & Colitis 360 · 7
Tu1302 Anti-TNF-α Induction Regimen Modulates Gut Microbiota Molecular Composition While Inducing Clinical Response in Crohn's Disease Patients: Toward a Personalized Medicine
2015 · Franco Scaldaferri, Viviana Gerardi, et al. · Gastroenterology · 6
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study
2025 · Franco Scaldaferri, Antonio Maria D’Onofrio, et al. · Microorganisms · 5
PDF
Monitoring the psychopathological profile of inflammatory bowel disease patients treated with biological agents: a pilot study
2024 · Antonio M. D’ONOFRIO, Lodovico M. BALZONI, et al. · Minerva Gastroenterology · 5
Works count: 72
Citation count: 678
H-index: 14
I10-index: 18
Year
Topic
Type